Blog - Page 1401 of 5714

TuesdayMay 04, 2021 10:17 am

QualityStocksNewsBreaks – Amesite Inc. (NASDAQ: AMST) Expands Wayne State University Partnership Through Advanced Technology Certificate Programs

Amesite (NASDAQ: AMST), an artificial intelligence software company providing advanced AI-powered online learning ecosystems for business and higher education, has expanded its partnership with Wayne State University. The partnership includes three-week certificate programs that are created for high school students, delivered by Amesite and offered through Wayne State, Michigan's third-largest institution of higher learning. The certificate programs cover 11 fields, including data science, smart manufacturing, electric vehicles and artificial intelligence. The programs are part of a 21st Century Community Learning Center, which operates in 24 Metro District schools and is funded through the Michigan Department of Education; the program is designed to enhance…

TuesdayMay 04, 2021 9:44 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Provides Update, Plans to Release FY2020 Financials

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has announced that it will file its 2020 audited financial statement on or before May 31, 2021. In addition, the company released a brief company update featuring highlights of 2020. The update noted that Q4 2020 product sales for the company totaled an estimated CDN $26.5 million, which was a 218% increase over the Q3. The company also completed its acquisitions of Acreage Florida Inc., PV (“PV”) and Mid-American Growers. RWBYF also entered into a definitive agreement to purchase one of only 21 cannabis licenses and operations in Illinois. The company…

MondayMay 03, 2021 3:20 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Eyes Significant Market Opportunity

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, raised eyebrows when it announced that XPhyto Laboratories Inc., its Alberta subsidiary, added mescaline production to its psychedelic medicine development programs earlier this year (https://ibn.fm/cHwJi). Mescaline has begun attracting legislative attention, much like was the case with cannabis, which gained widening legalization as state after state approved varied uses of hemp and cannabis within their political boundaries. Recently, California Senator Scott Wiener introduced a bill that would decriminalize select hallucinogenics, including mescaline, in part due to research from top medical universities indicating that such substances can have significant benefits…

MondayMay 03, 2021 3:17 pm

QualityStocksNewsBreaks – Infobird Co. Ltd. (NASDAQ: IFBD) Announces Intent to File Annual Report on Form 20-F

Infobird (NASDAQ: IFBD), a software-as-a-service (“SaaS”) provider of artificial intelligence (“AI”)-powered customer engagement solutions in China, today reported that on or before May 15, 2021, the company intends to file its annual report on Form 20-F with the U.S. Securities and Exchange Commission (“SEC”) for the fiscal year ended Dec. 31, 2020. After the company files the annual report, which will include Infobird’s audited consolidated financial statements, it will be available on the company’s website and through the SEC’s website at www.SEC.gov. To view the full press release, visit https://ibn.fm/5sGAk About Infobird Co. Ltd. Infobird, headquartered in Beijing, China, is a software-as-a-service…

MondayMay 03, 2021 2:59 pm

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Leverages Strategic Approach to Target Fast-Growing Market

Hero Technologies (OTC: HENC), a Delaware-based company founded in 2004, is building a vertically integrated business model and leverages a strategic approach as a multi-state operator across multiple sectors of the cannabis industry. These factors uniquely position HENC “to capitalize on the fast-growing market and the growing number of opportunities emerging as a result of legalization and increased popularity among consumers,” reads a recent article. The article notes that the global CBD market, which was valued at $2.8 billion in 2020, is projected to reach $13.4 billion by 2028, growing at a 21.2% CAGR, while “the global legal cannabis market…

MondayMay 03, 2021 2:48 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) On Pace to Outperform in Commercial REE Carbonate Production

Energy Fuels (NYSE American: UUUU) (TSX: EFR) has received the first shipments of monazite from The Chemours Company’s Offerman Mineral Sand Plant in Georgia. The delivery sets the wheels in motion for UUUU to produce mixed rare earth elements (“REE”) carbonate and subsequently sell the product to Neo Performance Materials’ REE separation plant in Europe “for production of value-added REE products available to U.S. and European manufacturers,” says a recent article. While the initial production phase of the REE value chain holds great potential for UUUU, the company is still focused on its core business: uranium. “If successful in the…

MondayMay 03, 2021 1:07 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Makes Headway into Canadian Cannabis Vape Market with 25,000 Unit Production Run

Production underway for 25,000 vape cartridges using PULL full spectrum oil formulations, including Super Lemon Haze, Grand Daddy Purple and Girl Scout Cookies/GSK Company estimates retail sales revenue for this production run will be approximately $750,000 60% of respondents in StatCan’s Canadian 2020 Cannabis Survey that used vaporizer for cannabis in the last 12 months used oil/extracts “Cannabis 2.0,” the colloquial term for legalization of cannabis derivatives in Canada late in 2019, represented the outset of new trends in how people consume cannabis products with the accessibility of goods like drinks and vape products. While some companies have devoted considerable…

MondayMay 03, 2021 12:51 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Eyes Rapid Progress to Clinical Studies for Psychedelic Drug Candidates

Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has completed key in-vitro and in-vivo research studies. The company recently announced completion of its 20th pre-clinical study and the progression of two psychedelic drug candidates: CYB003 and CYB004. According to Cybin, the studies were completed in record time, in part due to close collaboration with the company’s partners and contractors. “Excellent teamwork and fully supportive partners have greatly facilitated the advancement of these two new therapeutic candidates with enhanced and improved properties,” said Michael Palfreyman, Cybin’s chief R&D officer, in a…

MondayMay 03, 2021 12:32 pm

Healthtech Solutions Inc. (HLTT) Adopts New Portfolio Model with Varian Bio Acquisition

McKinsey & Company notes that portfolio model is growing in popularity amongst companies and investors HLTT recently acquired precision oncology company Varian Biopharma Report shows that more than $5.5 billion in capital has been raised in past six years by companies with biotech portfolio models An emerging trend in biotechnology involves abandoning a single shot on goal approach in favor of a broader strategy with different portfolio companies under one umbrella. The old incubator approach with a new flare, the trend involves a portfolio manager utilizing a variety of skillsets to assemble a group of subsidiaries, each committed to a…

Site Search

Company Search